Oncology at South Texas Veterans Health Care System

Applications Closed for 2025-2026 Residency Year

Applications for the PGY2 Oncology Pharmacy Residency Program will be closed for the 2025-2026 year as the program has decided to early commit a PGY1 resident from the South Texas Veterans Health Care System.

South Texas Veterans Health Care System, Audie L. Murphy Hospital in conjunction with the University of Texas, College of Pharmacy

Major areas of clinical involvement are supportive care and prevention or management of antineoplastic drug toxicity. Accordingly, oncology/hematology pharmacists are involved in nausea and vomiting prevention, pain management, infection treatment, nutritional support, antineoplastic toxicity of prevention and management, therapeutic drug monitoring, chemotherapy regimen dosing and design, and extravasation management. These services are provided to the medical oncology and hematology/BMTU services at STVHCS in both inpatient and outpatient settings.

Other areas of involvement are coordination and supervision of chemotherapy preparation, patient and staff education, investigational drug control for all southwest Oncology Group (SWOG) protocols and provision of drug information.

Oncology Pharmacy Residents are involved in all of these activities to ensure the development of a clinician with comprehensive oncology pharmacy skills. Teaching and clinical research opportunities are also available.

Responsibilities and activities are structured to meet or exceed ASHP standards for oncology pharmacy practice.

The University of Texas at Austin and its affiliated institutions are an Equal Opportunity/Affirmative Action Employer. Qualified women and minorities are encouraged to apply. Security sensitive; conviction verification conducted on applicant selected.

Required Learning Experiences

Oncology Pharmacy Orientation (1 month)
Medical Oncology Consults (2 months)
Hematology Consults (2 months)
Bone Marrow Transplant (Brooke Army Medical Center) (1 month)
Chemotherapy Infusion Clinic (1 month)
Breast Cancer Clinic (1 month)
Research/Administration (1 month)
Gynecologic Malignancies** (1 month)
Medical Oncology Longitudinal Clinic (once per week during oncology focused clinical rotation month)
Hematology Longitudinal Clinic (once per week during hematology focused clinical rotation)
Inpatient Hematology/Oncology Weekend Staffing every 3^rd weekend

**Gynecologic Malignancies will be covered via Virtual Rotation with Purdue University

Elective Learning Experiences (3 months, limit 2 months off-site*)

Repeat Required Rotation
Bone Marrow Transplant (Brooke Army Medical Center or Nashville Veterans Affairs**)
Palliative Care
Phase I Clinical Trials (NEXT Oncology)
Precision Oncology (Virtual rotation with Durham VA)
Malignant Hematology Consults (University Hospital)

*Additional off-site rotation experiences may be possible on a case-by-case basis, but are not guaranteed

**Nashville VA BMT rotation experience would be funded on own by the resident

Other Requirements for Completion

Research/Quality Improvement Project
Poster Presentations
A Manuscript/Publication
Medication Use Evaluation
Drug Information Questions/Pharmacy Newsletter
VA Pharmacology Grand Rounds
In-Services
Journal Club and Case Presentations
Didactic Lectures
Pharmacy Committees
University of Texas Pharmacotherapy Rounds
University of Texas Pharmacotherapy Seminar

Oncology at South Texas Veterans Health Care System

Applications Closed for 2025-2026 Residency Year

John Malamakal, Pharm.D., MS, BCPS, BCOP

Critical Objectives

Required Learning Experiences

Elective Learning Experiences (3 months, limit 2 months off-site*)

Other Requirements for Completion

Residency Details

Location

Length of Residency

Start Date

Positions Available

Application Requirements

Stipend

Previous Residents Include